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Results

Background
The Boston Keratoprosthesis Type 1 (KPro) is a surgical
device used in patients who have failed traditional corneal
transplant treatment or are poor candidates for it.1 Candidates
for KPro often have advanced anterior segment disease that
predisposes them to developing glaucoma.2 As a result, these
patients may require both a KPro, to treat their corneal
pathology, and a glaucoma drainage implant (GDI), to treat
their glaucoma. To date, there have been no long-term studies
comparing the order of GDI placement with KPro surgery and
how it affects surgical outcomes.

Thirty-five eyes were included in the study, 17 in the sequential group and 18 in the concomitant group. The mean follow-up time was 50.5 ± 20.8
months in the sequential group and 30.8 ± 19.7 months in the concomitant group (P=0.007). The overall failure rates were 23.5% (n=4/17) in the
sequential group and 27.8%, (n=5/18) in the concomitant group (P=0.486). The most frequent complication was GDI erosion, which occurred in
23.5% (n=4/17) in the sequential group and in 27.8% (n=5/18) in the concomitant group (P=1.000). BCVA was better in the concomitant group
after 1 year (P=0.020) and at the last follow-up visit (P=0.001).
Figure 1: Boston
Keratoprosthesis Type 1

Figure 2: Distribution of Intraocular Pressure at
Baseline and Follow-Up

Figure 3: Distribution of Best-Corrected Visual
Acuity at Baseline and Follow-Up

Specific Aim
This study aimed to evaluate the outcomes of patients
undergoing both GDI placement and KPro surgery.

Methods
This was a multicenter retrospective study of patients receiving
GDI and KPro in the same eye. Patients were divided into 2
groups: GDI placement prior to KPro surgery (sequential
group) or GDI placement concomitant with KPro surgery
(concomitant group). Outcome measures included intraocular
pressure (IOP), best-corrected visual acuity (BCVA), glaucoma
medications, surgical complications, and failure, which was
defined as the following:
1. IOP > 21, less than a 20% reduction from baseline IOP, or
IOP < 5 for 2 consecutive follow-up visits
2. Any glaucoma reoperation
3. Loss of light perception
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Figure 4: Kaplan-Meier Plots of the
Cumulative Failure Rate

Table 1: Best-Corrected Visual Acuity at Time of Boston Keratoprosthesis and
at Last Visit
Follow-Up Visit	
  
At Time of KPro	
  
logMAR BCVA, mean (CI) (n)	
  
Snellen	
  

Sequential (n=17)	
  

Concomitant (n=18)	
  

P-Value	
  

2.1 (1.9, 2.3) (17)	
  

1.8 (1.5, 2.1) (18)	
  

0.126	
  

20/2518	
  

20/1262	
  

N/A	
  

2.1 (1.7, 2.5) (17)	
  

1.1 (0.7, 1.5) (18)	
  

0.001	
  

20/2518	
  

20/252	
  

N/A	
  

Last Visit	
  
logMAR BCVA, mean (CI) (n)	
  
Snellen	
  

Discussion
The results demonstrate that GDI placement at the time of KPro surgery had similar failure rates, but significantly favorable visual
outcomes compared to sequential surgeries.
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